Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: A potential role in calcium buffering and sarcolemmal stability

Muscle and Nerve

Volumn 39, Issue 2, 2009, Pages 167-176

  Matsumura, Cintia Yuri ^a   Pertille, Adriana ^a   Albuquerque, Tereza C P ^a   Neto, Humberto Santo ^a   Marques, Maria Julia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Beta dystroglycan; Calcium; Calsequestrin; Diltiazem; Evans blue dye; Mdx; Muscle degeneration; Verapamil

Indexed keywords

BETA DYSTROGLYCAN; CALCIUM; CALCIUM CHANNEL; CALSEQUESTRIN; CREATINE KINASE; DILTIAZEM; DYSTROPHIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIAPHRAGM; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; HEART MUSCLE; HISTOPATHOLOGY; IMMUNOBLOTTING; MALE; MOLECULAR INTERACTION; MOUSE; MUSCLE ATROPHY; MUSCLE NECROSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SARCOLEMMA; SARCOPLASMIC RETICULUM; STATISTICAL SIGNIFICANCE; STERNOCLEIDOMASTOID MUSCLE; TIBIALIS ANTERIOR MUSCLE; TREATMENT OUTCOME; WESTERN BLOTTING; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALSEQUESTRIN; CREATINE KINASE; DILTIAZEM; DISEASE MODELS, ANIMAL; DYSTROGLYCANS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE FIBERS, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; SARCOLEMMA; VERAPAMIL;

EID: 60549115816     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21188     Document Type: Article

References (53)

1. Barresi R, Campbell KP. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 2006;119:199-207.
2. Beard NA, Laver DR, Dulhunty AF. Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog Biophys Mol Biol 2004;85:33-69.
3. Beard NA, Sakowska MM, Dulhunty AF, Laver DR. Calsequestrin is an inhibitor of skeletal muscle ryanodine receptor calcium release channels. Biophys J 2002;82:310-320.
4. Bertorini TE, Bhattacharya SK, Palmieri GM, Chesney CM, Pifer D, Baker B. Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 1982;32:1088-1092.
5. Bertorini TE, Palmieri GMA, Griffin JW, Igarashi M, McGee J, Brown R, et al. Effect of chronic treatment with the calcium antagonist diltiazem in Duchenne muscular dystrophy. Neurology 1988;38:609-613.
6. Bulfield G, Siller WG, Wight PAL, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 1984;81:1189-1192.
7. Coulton GR, Curtin NA, Morgan JE, Partridge TA. The mdx mouse skeletal muscle myopathy: II. Contractile properties. Neuropathol Appl Neurobiol 1988;14:299-314.
8. Courdier-Fruth L, Barman L, Wettstein P, Meier F. Detection of glucocorticoid-like activity in traditional Chinese medicine used for the treatment of Duchenne muscular dystrophy. Neuromuscul Disord 2003;13:699-704.
9. Culligan K, Banville N, Dowling P, Ohlendieck K. Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. J Appl Physiol 2002;92:435-445.
10. De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Fraysse B, et al. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J Pharmacol Exp Ther 2003;304:453-463.
11. Dehpour AR, Mousavizadeth K, Gerayessh-Nejad S. Calcium release by diltiazem from isolated sarcoplasmic reticulum of rabbit skeletal muscle. Gen Pharmacol 1998;31:463-468.
12. Doran P, Dowling P, Donoghue P, Buffini M, Ohlendieck K. Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochem Biophys Acta 2006;1764:773-785.
13. Dowling P, Lohan J, Ohlendieck K. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan. Eur J Cell Biol 2003;82:222-230.
14. Engel AG, Yamamoto M, Fischbeck KH. Dystrophinopathies. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw-Hill; 1994. p 1133-1187.
15. Ervasti JM. Dystrophin, its interaction with other proteins, and implications for muscular dystrophy. Biochem Biophys Acta 2007;1772:108-117.
16. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell K. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 1990;345:315-319.
17. Fong PY, Turner PR, Denetclaw WF, Steinhardt RA. Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 1990;250:673-676.
18. Franco-Obregon Jr A, Lansman JB. Mechanosensitive ion channels in skeletal muscle from normal and dystrophic mice. J Physiol 1994;481:299-309.
19. Gramolini AO, Barton EA, Tinsley JM, Ferris MJ, Cartaud A, Cartaud J, et al. Muscle and neural isoform of agrin increase utrophin expression in cultured myotubes via a transcriptional regulatory mechanism. J Biol Chem 1998;273:736-743.
20. Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A. Towards developing standard operating procedures for preclinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis 2008;31:1-19
21. Grounds MD, Sorokin L, White J. Strength at the extracellular matrix-muscle interface. Scand J Med Sci Sports 2005;15:381-391.
22. Grounds MD, Torrisi J. Anti-TNFa (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 2004;18:676-682.
23. Hamer PW, Mcgeachie JM, Davies MJ, Grounds MD. Evans blue dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat 2002;200:69-79.
24. Hopf FW, Reddy P, Hong J, Steinhardt RA. A capacitative calcium current in cultured skeletal muscle cells is mediated by the calcium-specific leak channel and inhibited by dihydropyridine compounds. J Biol Chem 1996;271:358-367.
25. 2+ homeostasis and cell damage in myopathic skeletal muscle cells. Biochem Pharmacol 2005;70:740-751.
26. Janis RA, Silver PJ, Triggle DJ. Drug action and cellular calcium regulation. Adv Drug Res 1987;16:309-591.
27. Johnson PL, Bhattacharya SK. Regulation of membrane-mediated chronic muscle degeneration in dystrophic hamsters by calcium-channel blockers - diltiazem, nifedipine and verapamil. J Neurol Sci 1993;115:76-90.
28. Lefaucheur JP, Pastoret C, Sebille A. Phenotype of dystrophinopathy in old mdx mice. Anat Rec 1995;242:70-76.
29. Lefkowitz DL, Lefkowitz SS. Fascioscapulohumeral muscular dystrophy: a progressive degenerative disease that responds to diltiazem. Med Hypotheses 2005;65:716-721.
30. + channels. Proc Natl Acad Sci U S A 2000;97:4950-4955.
31. Marques MJ, Luz MAM, Minatel E, Santo Neto H. Muscle regeneration in dystrophic mdx mice is enhanced by isosorbide dinitrate. Neurosci Lett 2005;382:342-345.
32. Marques MJ, Machado RV, Minatel E, Santo Neto H. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness: studies in mdx sternomastoid, diaphragm and tibialis anterior. Muscle Nerve 2008;37:61-67.
33. Marques MJ, Matsumura CY, Santo Neto H. Alterations in the permeability of dystrophic fibers during neuromuscular junction development. Acta Biol Hung 2007;58:1-9.
34. Muntoni F, Mateddu A, Marchei F, Clerk A, Serra G. Muscular weakness in the mdx mouse. J Neurol Sci 1993;120:71-77.
35. Pernice W, Beckmann R, Ketelsen UP, Frey M, Schmidt-Redemann B, Haap KP, et al. A double-blind placebo controlled trial of diltiazem in Duchenne dystrophy. Klin Wochenschr 1988;66:565-570.
36. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 1993;90:3710-3714.
37. Porter JD, Merrian AP, Leahy P, Gong B, Khann S. Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Hum Mol Genet 2003;12:1813-1821.
38. Pozzan T, Rizzuto R, Volpe P, Meldolesi J. Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 1994;74:595-636.
39. Robert V, Massimino ML, Tosselo V, Marsault R, Cantini M, Sorrentino V. Alterations in calcium handling at the subsarcolemmal level in mdx myotubes. J Biol Chem 2001;276:4647-4651.
40. Rossi AE, Dirksen RT. Sarcoplasmic reticulum: the dynamic calcium governor of muscle. Muscle Nerve 2006;33:715-731.
41. Shavlakadze T, White J, Hoh JFY, Rosenthal N, Grounds MD. Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice. Mol Ther 2004;10:829-843.
42. Stedman HH, Sweeny HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, et al. The MDX mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991;352:536-538
43. Straub V, Rafael JA, Chamberlain JS, Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemma disruption. J Cell Biol 1997;139:375-385.
44. Tanabe Y, Esaki K, Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol 1986;69:91-95.
45. Tidball JG, Wehling-Henriks M. Evolving therapeutics strategies for Duchenne muscular dystrophy: targeting downstream events. Pediatr Res 2004;56:831-841.
46. Turner PR, Fong P, Denetclaw W, Steinhardt RA. Increased calcium influx in dystrophic muscle. J Cell Biol 1991;115:1701-1712.
47. Vandebrouck A, Martin D, Colson-Van Schoor M, Debaix H, Gailly P. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers. J Cell Biol 2002;158:1089-1096.
48. Vandebrouck A, Sabourin J, Rivet J, Balghi H, Sebille S, Kitzis A, et al. Regulation of capacitative calcium entries by α1-syntrophin: association of TRPC1 with dystrophin complex and the PDZ domain of α1-syntrophin. FASEB J 2007;21:608-617.
49. Voisin V, Sébrié C, Matecki S, Yu H, Gillet B, Ramonatxo M, et al. L-arginine improves dystrophic phenotype in mdx mice. Neurobiol Dis 2005;20:123-130.
50. Wang T, Tsai LI, Schwartz A. Effects of verapamil, diltiazem, nisoldipine and felodipine on sarcoplasmic-reticulum. Eur J Clin Pharmacol 1984;100:253-261.
51. Wells DJ. Therapeutic restoration of dystrophin expression in Duchenne muscular dystrophy. J Muscle Res Cell Motil 2006;27:387-398.
52. Whitehead NP, Yeung EW, Allen DG. Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin Exp Pharmacol Physiol 2006;33:657-662.
53. Yoshida M, Yonetani A, Shirasaki T, Wada K. Dietary NaCl supplementation prevents muscle necrosis in a mouse model of Duchenne muscular dystrophy. Am J Physiol Regul Integr Comp Physiol 2006;290:R449-R455.